HISTORY	MATURATION INDEX
SPECIMEN SOURCE: CERVICAL/VAGINAL/1 ThinPrep® Slide LMP: 01/30/08	ESTROGEN EFFECT (HORMONAL PATTERN): COMPATIBLE WITH AGE AND/OR HISTORY.

PAP TEST RESULTS WITH IMAGER

Date Reported: 2/13/2008

ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE. Favor reactive changes. Repeat when clinically appropriate. Endocervical cells or associated benign metaplastic cells present.

Management Recommendation: Cytology ASC-US, HPV Positive: Colposcopy, as suggested by the Consensus Workshop. (Obstetrics and Gynecology 2004;103:302-309)

Pathologist: JOHN COMPAGNO M.D.,MEDICAL DIRECTOR

HUMAN PAPILLOMA VIRUS TEST RESULTS BY PCR

Date Reported: 2/14/2008

HPV Type	16,61
Risk	High

This sample is positive for the following HPV type(s) (16,61). This HPV infection is considered a high risk for development of dysplasia or neoplasia of the anogenital tract.  HPV of the anogenital tract is a sexually transmitted disease with implications for the development of organ specific cancers such as cervical carcinoma. The diagnosis of dysplasia and cancer are based on the morphologic assessment of the Pap smear or tissue obtained from biopsy.

Pathologist: JOHN COMPAGNO, M.D., MEDICAL DIRECTOR

CHLAMYDIA/GONORRHEA TEST RESULTS BY PCR

Date Reported: 2/14/2008

Chlamydia	Negative
Gonorrhea	Negative

This sample is negative for evidence of either Chlamydia trachomatis or of Neisseria gonorrhea DNA as detected by methods of the polymerase chain reaction.  If clinical suspicion of infection remains, repeat collection and testing by culture based methodology is recommended.

Pathologist: JOHN COMPAGNO, M.D., MEDICAL DIRECTOR

Note: For FDA comments, see http://www.wcpl.com/FDA.asp

Note: The following tests are available for 60 days post collection. Please call (800) 794-9737 for additional testing, if desired.

• HERPES SIMPLEX VIRUS (HSV) BY PCR
• CYSTIC FIBROSIS (CF) BY PCR
• INHERITED THROMBOPHILIA (IHT) BY PCR

712 Alfred Nobel Drive . Hercules, CA 94547 . toll free 800.794.9737 . fax 510.662.5240 . www.wcpl.com . John Compagno, M.D., Medical Director

PATHOLOGY/CYTOPATHOLOGY CONSULTATION REPORT